The Ministry of Health in Basque Country has selected Hayes to support evidence-based decisions on new health technologies. The Basque Office for Health Technology Assessment will utilize Hayes research to support its drive to improve patient care and outcomes, and to make evidence-based decisions about new healthcare technology purchases.
Hospital Israelita Albert Einstein has selected Hayes to support its decision-making process for the acquisition of new health technologies.
Helsana, Switzerland-based health insurer, has subscribed to Hayes Technology Prognosis, a horizon-scanning service that provides hospitals, insurers, and policy makers with a forward-looking view of the changing health technology landscape. Helsana will use Prognosis information to stay abreast of emerging healthcare technologies and to create actuarial models for calculation of future healthcare costs.
Beat Seiler, chief medical officer of Helsana, said: As Switzerland-based health insurer, Helsana knows that timely and sound information about technological innovation and novel medication is vital. Hayes Prognosis will be an important tool for Helsana’s medical officers because it delivers unbiased, evidence-based support for claims inquiries and negotiations to extend coverage. We are confident that Hayes provides us access to impartial background information and competent appraisals.
